These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 18647852

  • 1. Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation.
    Teng YK, Levarht EW, Toes RE, Huizinga TW, van Laar JM.
    Ann Rheum Dis; 2009 Jun; 68(6):1011-6. PubMed ID: 18647852
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.
    Teng YK, Levarht EW, Hashemi M, Bajema IM, Toes RE, Huizinga TW, van Laar JM.
    Arthritis Rheum; 2007 Dec; 56(12):3909-18. PubMed ID: 18050222
    [Abstract] [Full Text] [Related]

  • 3. Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis.
    Vos K, Thurlings RM, Wijbrandts CA, van Schaardenburg D, Gerlag DM, Tak PP.
    Arthritis Rheum; 2007 Mar; 56(3):772-8. PubMed ID: 17328049
    [Abstract] [Full Text] [Related]

  • 4. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis.
    Leandro MJ, Cambridge G, Ehrenstein MR, Edwards JC.
    Arthritis Rheum; 2006 Feb; 54(2):613-20. PubMed ID: 16447239
    [Abstract] [Full Text] [Related]

  • 5. Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis.
    Roll P, Palanichamy A, Kneitz C, Dorner T, Tony HP.
    Arthritis Rheum; 2006 Aug; 54(8):2377-86. PubMed ID: 16869000
    [Abstract] [Full Text] [Related]

  • 6. Bone marrow B-lineage cells in patients with rheumatoid arthritis following rituximab therapy.
    Leandro MJ, Cooper N, Cambridge G, Ehrenstein MR, Edwards JC.
    Rheumatology (Oxford); 2007 Jan; 46(1):29-36. PubMed ID: 16735454
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis.
    Thurlings RM, Teng O, Vos K, Gerlag DM, Aarden L, Stapel SO, van Laar JM, Tak PP, Wolbink GJ.
    Ann Rheum Dis; 2010 Feb; 69(2):409-12. PubMed ID: 19596693
    [Abstract] [Full Text] [Related]

  • 11. Delayed acquisition of somatic hypermutations in repopulated IGD+CD27+ memory B cell receptors after rituximab treatment.
    Muhammad K, Roll P, Einsele H, Dörner T, Tony HP.
    Arthritis Rheum; 2009 Aug; 60(8):2284-93. PubMed ID: 19644860
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.
    Cañete JD, Celis R, Moll C, Izquierdo E, Marsal S, Sanmartí R, Palacín A, Lora D, de la Cruz J, Pablos JL.
    Ann Rheum Dis; 2009 May; 68(5):751-6. PubMed ID: 18495732
    [Abstract] [Full Text] [Related]

  • 13. Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment.
    Roll P, Dörner T, Tony HP.
    Arthritis Rheum; 2008 Jun; 58(6):1566-75. PubMed ID: 18512772
    [Abstract] [Full Text] [Related]

  • 14. Detection, identification and in vivo treatment responsiveness of bone morphogenetic protein (BMP)-activated cell populations in the synovium of patients with rheumatoid arthritis.
    Verschueren PC, Lories RJ, Daans M, Théate I, Durez P, Westhovens R, Luyten FP.
    Ann Rheum Dis; 2009 Jan; 68(1):117-23. PubMed ID: 18276742
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of candidate genes for rituximab response in rheumatoid arthritis patients by microarray expression profiling in blood cells.
    Julià A, Barceló M, Erra A, Palacio C, Marsal S.
    Pharmacogenomics; 2009 Oct; 10(10):1697-708. PubMed ID: 19842941
    [Abstract] [Full Text] [Related]

  • 18. Tumor necrosis factor alpha blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue.
    Smeets TJ, Kraan MC, van Loon ME, Tak PP.
    Arthritis Rheum; 2003 Aug; 48(8):2155-62. PubMed ID: 12905468
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of anti-CD20 treatment in patients with rheumatoid arthritis resistant to a combination of methotrexate/anti-TNF therapy.
    Bokarewa M, Lindholm C, Zendjanchi K, Nadali M, Tarkowski A.
    Scand J Immunol; 2007 Oct; 66(4):476-83. PubMed ID: 17850593
    [Abstract] [Full Text] [Related]

  • 20. Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia.
    Atkins SR, Turesson C, Myers JL, Tazelaar HD, Ryu JH, Matteson EL, Bongartz T.
    Arthritis Rheum; 2006 Feb; 54(2):635-41. PubMed ID: 16447242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.